Printer Friendly
The Free Library
14,678,926 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Stef International Appoints Veteran Marketing Professional Daniel McCoy to the Position of President and COO and Announces Preliminary Results of Double Blind Placebo Hair Growth Study.


TORONTO--(BUSINESS WIRE)--Oct. 24, 1997--Stef International (OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system.
: SEFFF, CANADIAN DEALING NETWORK Canadian Dealing Network (CDN)

The organized OTC market of Canada. Formerly known as the Canadian Over-the-Counter Automated Trading System (COATS), the CDN became a subsidiary of the Toronto Stock Exchange in 1991.
 STEF ) STEF INTERNATIONAL CORPORATION (Canadian Dealing Network Stock Symbol - STEF; NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
 Bulletin Board Symbol - SEFFF), 30 percent of shares of Stef International are held by the pharmaceutical company Draxis Health Inc. (TSE See Tokyo Stock Exchange.

TSE

1. See Tokyo Stock Exchange (TSE).

2. See Toronto Stock Exchange (TSE).
 - DAX; NASDAQ - DRAXF) Stef announced today that it has appointed Daniel McCoy as President and Chief Operating Officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
 for their Toronto and Phoenix based network marketing operations.

Mr. McCoy began his career in network marketing in 1982 as a cofounder co·found  
tr.v. co·found·ed, co·found·ing, co·founds
To establish or found in concert with another or others.



co·found
 of a startup nutritional company. He is a visionary who is well versed in the Network Marketing Industry with over 15 years experience.

In January 1992, he began as a distributor with Quorum International, a security and consumer electronics start-up company which later added a nutritional products division. His organization built a 300,000 plus distributorship in 16 countries, which generated sales in excess of 150 million dollars in their first 24 months and 250 million in their third year. "With Stef International, I see an opportunity even larger than Quorum. Stef has the leadership, systems, products and compensation and is now attracting key leaders in the industry. In this business timing is everything and the time is right now for Stef."

Stef International now has preliminary results on their double blind placebo hair study trial performed at a Canadian hospital under the supervision of the Dermatology Department. The purpose of the study was to determine the efficacy of its hair rejuvenation system on male pattern baldness male pattern baldness
n.
A progressive, diffuse loss of scalp hair in men that begins in the twenties or early thirties, depends on the presence of the androgenic hormone testosterone, and is caused by a combination of genetic and hormonal factors.
. Preliminary results indicate that approximately 45 percent of the patients treated with Stef's Hair Rejuvenation System experienced hair growth and 90 percent (36 out of 40) treated with the system expressed positive comments. Complete study results will be forthcoming.

CONTACT: Stef International Corporation

Leonard Levitsky, 905/ 672-3212 during business

hours, Eastern Standard Time
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 24, 1997
Words:306
Previous Article:Golden Phoenix Minerals Inc. Completes Purchase of Borealis Mine in Nevada.
Next Article:Phonettix Intelecom Ltd. Results For The Year Ended August 31, 1997 Increased Revenues Increased Profit.
Topics:



Related Articles
Boosting immunity in the elderly....
Probe turns up flaws in Alzheimer's study. (University of California, Los Angeles, study of tetrahydroaminoacridine as treatment)
BIOLIGHT DEVELOPS UNIQUE METHOD IN WOUND HEALING.
Selected Ongoing Clinical Trials [*].
Selected ongoing clinical trials. (Featured CME Topic: Diabetes Mellitus).
Selected ongoing clinical trials #. (Featured CME Topic: Osteoporosis).
PHASE 3 TRIAL/STUDY OF ALDURAZYME FOR MPS I PROMISING.
THGRF PROMISING TO BENEFIT COPD PATIENTS WITH MUSCLE WASTING.
Does scientific evidence support the use of non-prescription supplements for treatment of acute menopausal symptoms such as hot flushes?(Review)
Kyorin Announce Clinical Trial Result for Mucodyne.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles